Supplementary Data S1, S2 from Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1. FGTI-2734 does not induce apoptosis in wild-type RAS human cancer cells and normal cells; Supplementary Figure 2. FGTI-2734 inhibits in vivo growth of PDXs from pancreatic cancer patients.
Authors: Aslamuzzaman Kazi, Shengyan Xiang, Hua Yang, Liwei Chen, Perry Kennedy, Muhammad Ayaz, Steven Fletcher, Christopher Cummings, Harshani R. Lawrence, Francisca Beato, Ya'an Kang, Michael P. Kim, Andrea Delitto, Patrick W. Underwood, Jason B. Fleming, Jose G. Trevino, Andrew D. Hamilton, Said M. Sebti
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361817069